Background. Carboplatin is an analogue of cisplatin with less nonhematologic toxicity than
โฆ LIBER โฆ
Carboplatin in childhood brain tumors: A children's cancer study group phase II trial
โ Scribed by Paul S. Gaynon; Lawrence J. Ettinger; Edward S. Baum; Stuart E. Siegel; Mark D. Krailo; G. Denman Hammond
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 482 KB
- Volume
- 66
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
A phase II study of carboplatin in child
โ
Lawrence J. Ettinger; Paul S. Gaynon; Mark D. Krailo; Ning Ru; Edward S. Baum; S
๐
Article
๐
1994
๐
John Wiley and Sons
๐
English
โ 442 KB
๐ 2 views
A phase II trial of carboplatin in patie
โ
Leonard Saltz; Gregory Lauwers; Jill Wiseberg; David Kelsen
๐
Article
๐
1993
๐
John Wiley and Sons
๐
English
โ 444 KB
๐ 1 views
Cisplatin in recurrent pediatric brain t
โ
Charles L. Sexauer; Atiya Khan; Peter C. Burger; Jeffrey P. Krischer; Jan Van Ey
๐
Article
๐
1985
๐
John Wiley and Sons
๐
English
โ 417 KB
๐ 1 views
Forty-six evaluable pediatric patients with primary recurrent brain tumors resistant to standard therapy were treated with cisplatin, 60 mg/m\*/day, X2 days every 3 to 4 weeks, to study the efficacy and toxicity of this drug. Complete and partial responses, documented by computed tomography (CT) sca
A Phase II study of carboplatin as a tre
โ
Lawrence J. Ettinger; Percy Ivy; Paul S. Gaynon; Alice G. Ettinger; Wen Liu-Mare
๐
Article
๐
1997
๐
John Wiley and Sons
๐
English
โ 79 KB
๐ 2 views
## BACKGROUND. Carboplatin is an analogue of cisplatin with less nonhematologic toxicity
A Southwest Oncology Group phase II tria
โ
G. Thomas Budd; Stephanie Green; Laurence H. Baker; Evan P. Hersh; James K. Weic
๐
Article
๐
1991
๐
John Wiley and Sons
๐
English
โ 175 KB
๐ 1 views
A Southwest oncology group phase ii tria
โ
Lawrence Helson; G. Thomas Budd
๐
Article
๐
1992
๐
John Wiley and Sons
๐
English
โ 129 KB
๐ 1 views